Bill Haney’s Dragonfly Therapeutics is making the vault between biotech startup and the next big level: adding clinical-stage compounds to its own fledgling...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
By Sungho Han, PhD, and Allan I. Levey, MD, PhD When science changes, it often takes a long time for nonscientists to catch up. The prevailing...
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development. The post Animal...
Plexium Inc. and AbbVie Inc. entered into an exclusive strategic collaboration to develop and commercialize novel Targeted Protein Degradation (TPD) therapeutics...
GSK’s strong Q1 driven by COVID-19, returning demand for shingles vaccine Published: Apr 27, 2022 By Mark Terry BioSpace GlaxoSmithKline exceeded expectations...
Enzolytics Inc (OTCMKTS: ENZC) is making an explosive move up the charts after the Company announced a progress update and more on its future plans. The...
VANCOUVER, BC / TheNewswire / April 21, 2022 / AREV Life Sciences Global Corp. (CSE:AREV) (OTC: AREVF) ("AREV" or the "Company") AREV announced today its...
Matthew Ros → The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF mutations...
CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies...
Only Industry-Specific Event for ARDS Drug Developers The post 2nd ARDS Drug Development Summit appeared first on .
David Denton → The two major Covid-19 vaccine competitors, Pfizer and Moderna, will both have new finance chiefs within a week of each other: At Pfizer,...
Here's what you need to know about buying penny stocks on April 12th The post Top Penny Stocks to Buy? 3 As Stock Futures Climb Before...
After a Covid-19 vaccine success with partner Pfizer, and as the rest of its mRNA pipeline starts churning out data, BioNTech wants to go another delivery...
A research team at Wyss has discovered that applying mechanical forces that mimic breathing motions to lung cells on a chip suppresses influenza virus...
A human lung chip is helping researchers discover therapeutics for respiratory diseases like flu and COVID-19 by revealing how breathing impacts the lung's...
Building on the success of its COVID-19 mRNA vaccine, Moderna, Inc. is partnering with the nonprofit scientific research organization IAVI to develop treatments...
Boehringer Ingelheim announced the company's intention to pump €25 billion ($27 billion) into its R&D pipeline over the next five years.
Antibody-drug conjugates (ADCs) have been in development for decades, but only about a dozen have received FDA approval. Approximately 50 biopharma companies...
The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the...
Three of the earliest employees at G1 Therapeutics want to repeat the blueprint they laid at securing approval for CDK4/6 inhibitor Cosela by taking a...
CureVac and GlaxoSmithKline’s first attempt to develop a COVID-19 vaccine was a salutary reminder of the pitfalls in The post CureVac and GSK try again...
One of the biotechs betting on its vaccine platform proving useful in the long-term fight against Covid-19 reported a new batch of data Friday morning,...
Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.
Year three of the Covid-19 pandemic just began, but this far in, Omega Funds thinks it’s not too late to launch a biotech to fight SARS-CoV-2...
Pfizer CEO Albert Bourla raked in $24.3 million in total compensation in 2021. In other news, tinnitus (ringing or buzzing in one or both ears) might...
A Phase II clinical trial is testing a new drug's (BGE-175) ability to reduce mortality in older people hospitalized with COVID-19. Daily doses of BGE-175...
Antoine Yver → Centessa looked to Daiichi Sankyo to fill the CMO post with Antoine Yver back in May 2021, and now that Yver has garnered...
Robert Gourdie, a trailblazing cardiovascular scientist at the Fralin Biomedical Research Institute at VTC, is the first Virginia Tech researcher to receive...
The U.S. Food and Drug Administration turned down Ocugen’s Emergency Use Authorization (EUA) request for Covaxin in children 2 to 18 years. Covaxin is...